To overcome this obstacle, we have developed an original fluorescent-coupled immunocompetent ex vivo model of human HER2+ BC tumors (HER2+ 3DiBC) allowing functional analyses in three dimensions (3D). Here, ERBB2 is linked to breast cancer.